[Neuralgic amyotrophy (Parsonage-Turner syndrome) following streptokinase thrombolytic therapy]

Dtsch Med Wochenschr. 1995 Jul 7;120(27):959-62. doi: 10.1055/s-2008-1055432.
[Article in German]

Abstract

History and clinical findings: A 61-year-old man was given short-term thrombolytic treatment with streptokinase (1.5 million IU) 6 hours after the onset of anginal symptoms. Ten days later he complained of severe pain in the right upper arm and right shoulder, and also on the left 3 days later. Simultaneously there occurred severe atrophic pareses of the supra- and infraspinatus, deltoid and rhomboid muscles bilaterally, without sensory component.

Tests: When admitted to the neurological department 3 weeks later laboratory tests, immunological parameters, electrophoresis and cerebrospinal fluid were unremarkable. Radiological examinations of the cervical and thoracic vertebrae demonstrated moderate degenerative changes. Computed tomography and magnetic resonance imaging of the cervical vertebrae showed small disc protrusion and narrowing of the intervertebral foramina, but they could not explain the clinical picture. Electromyography demonstrated a bilateral peripheral neurogenic lesion without evidence of radicular distribution or any lesion of individual peripheral nerves. These findings led to the diagnosis of neuralgic amyotrophy (Parsonage-Turner syndrome).

Treatment and course: With analgesics and physiotherapy the pareses slowly regressed over the following months.

Conclusions: The infusion of streptokinase was the only probable cause found to explain the neuralgic amyotrophy, a connection that has never been reported until now.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Brachial Plexus Neuritis / chemically induced*
  • Brachial Plexus Neuritis / diagnosis
  • Cervical Vertebrae / pathology
  • Diagnosis, Differential
  • Electromyography
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Myocardial Infarction / drug therapy
  • Streptokinase / adverse effects*
  • Streptokinase / therapeutic use
  • Tomography, X-Ray Computed

Substances

  • Streptokinase